Patent details

EP2114432 Title: METHODS OF INCREASING CANCER SENSITIVITY TO CHEMOTHERAPEUTIC AGENTS USING CHIMERIC ISF35

Basic Information

Publication number:
EP2114432
PCT Application Number:
PCT/US/2007/086550
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP078549680
PCT Publication Number:
WO/2008/070743
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHODS OF INCREASING CANCER SENSITIVITY TO CHEMOTHERAPEUTIC AGENTS USING CHIMERIC ISF35
French Title of Invention:
PROCÉDÉS POUR RENDRE LES CANCERS PLUS SENSIBLES AUX AGENTS CHIMIOTHÉRAPEUTIQUES UTILISANT L'ISF35 CHIMÉRIQUE
German Title of Invention:
VERFAHREN ZUR ERHÖHUNG DER EMPFINDLICHKEIT VON KREBS AUF CHEMOTHERAPEUTISCHE MITTEL MIT CHIMÄREM ISF35
SPC Number:

Dates

Filing date:
05/12/2007
Grant date:
30/07/2014
EP Publication Date:
30/07/2014
PCT Publication Date:
12/06/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/11/2009
EP B1 Publication Date:
30/07/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
05/12/2014
Expiration date:
05/12/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/12/2007
 
 

Name:
Memgen LLC
Address:
402 West Broadway, Suite 400, San Diego, CA 92101, United States (US)

Inventor

Name:
PRUSSAK Charles E.
Address:
United States (US)

Priority

Priority Number:
868716 P
Priority Date:
05/12/2006
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/17;
Filing date Document type Number of pages